Dynavax Technologies Analyst Ratings
Dynavax Technologies Analyst Ratings
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a maintained with a price target of $25.00 to $27.00. The current price Dynavax Technologies (DVAX) is trading at is $14.32, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/03/2023 | 88.55% | JMP Securities | $25 → $27 | Maintains | Market Outperform |
| 11/03/2023 | 95.53% | HC Wainwright & Co. | $27 → $28 | Maintains | Buy |
| 08/04/2023 | 88.55% | HC Wainwright & Co. | → $27 | Reiterates | Buy → Buy |
| 08/04/2023 | 74.58% | JMP Securities | $24 → $25 | Maintains | Outperform |
| 05/03/2023 | 67.6% | JMP Securities | $25 → $24 | Maintains | Outperform |
| 05/03/2023 | 88.55% | HC Wainwright & Co. | → $27 | Reiterates | → Buy |
| 02/24/2023 | 74.58% | JMP Securities | $22 → $25 | Maintains | Market Outperform |
| 02/24/2023 | 88.55% | HC Wainwright & Co. | $28 → $27 | Maintains | Buy |
| 11/04/2022 | 46.65% | Goldman Sachs | $24 → $21 | Maintains | Buy |
| 09/27/2022 | 53.63% | JMP Securities | → $22 | Initiates Coverage On | → Market Outperform |
| 12/29/2021 | 95.53% | HC Wainwright & Co. | $23 → $28 | Maintains | Buy |
| 08/31/2021 | 60.61% | HC Wainwright & Co. | $20 → $23 | Maintains | Buy |
| 08/06/2021 | 32.68% | Goldman Sachs | → $19 | Initiates Coverage On | → Buy |
| 08/05/2021 | 39.66% | HC Wainwright & Co. | $16 → $20 | Maintains | Buy |
| 02/01/2021 | 4.75% | HC Wainwright & Co. | $14 → $15 | Maintains | Buy |
| 11/06/2020 | -2.23% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 08/07/2020 | -16.2% | HC Wainwright & Co. | $14 → $12 | Maintains | Buy |
| 08/03/2020 | -2.23% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 03/12/2020 | -16.2% | HC Wainwright & Co. | $13 → $12 | Reiterates | → Buy |
| 10/18/2019 | -9.22% | HC Wainwright & Co. | → $13 | Initiates Coverage On | → Buy |
| 07/11/2019 | — | Cantor Fitzgerald | Upgrades | Neutral → Overweight | |
| 11/06/2018 | 74.58% | RBC Capital | $26 → $25 | Maintains | Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/03/2023 | 88.55% | JMP 证券 | 25 美元 → 27 美元 | 维护 | 市场表现跑赢大盘 |
| 11/03/2023 | 95.53% | HC Wainwright & Co. | 27 美元 → 28 美元 | 维护 | 买 |
| 08/04/2023 | 88.55% | HC Wainwright & Co. | → 27 美元 | 重申 | 购买 → 购买 |
| 08/04/2023 | 74.58% | JMP 证券 | 24 美元 → 25 美元 | 维护 | 跑赢大盘 |
| 05/03/2023 | 67.6% | JMP 证券 | 25 美元 → 24 美元 | 维护 | 跑赢大盘 |
| 05/03/2023 | 88.55% | HC Wainwright & Co. | → 27 美元 | 重申 | → 购买 |
| 02/24/2023 | 74.58% | JMP 证券 | 22 美元 → 25 美元 | 维护 | 市场表现跑赢大盘 |
| 02/24/2023 | 88.55% | HC Wainwright & Co. | 28 美元 → 27 美元 | 维护 | 买 |
| 2022 年 4 月 11 日 | 46.65% | 高盛 | 24 美元 → 21 美元 | 维护 | 买 |
| 09/27/2022 | 53.63% | JMP 证券 | → 22 美元 | 启动覆盖范围开启 | → 市场跑赢大盘 |
| 12/29/2021 | 95.53% | HC Wainwright & Co. | 23 美元 → 28 美元 | 维护 | 买 |
| 08/31/2021 | 60.61% | HC Wainwright & Co. | 20 美元 → 23 美元 | 维护 | 买 |
| 2021 年 6 月 8 日 | 32.68% | 高盛 | → 19 美元 | 启动覆盖范围开启 | → 购买 |
| 08/05/2021 | 39.66% | HC Wainwright & Co. | 16 美元 → 20 美元 | 维护 | 买 |
| 2021 年 1 月 2 日 | 4.75% | HC Wainwright & Co. | 14 美元 → 15 美元 | 维护 | 买 |
| 11/06/2020 | -2.23% | HC Wainwright & Co. | 12 美元 → 14 美元 | 维护 | 买 |
| 08/07/2020 | -16.2% | HC Wainwright & Co. | 14 美元 → 12 美元 | 维护 | 买 |
| 2020 年 3 月 8 日 | -2.23% | HC Wainwright & Co. | 12 美元 → 14 美元 | 维护 | 买 |
| 03/12/2020 | -16.2% | HC Wainwright & Co. | 13 美元 → 12 美元 | 重申 | → 购买 |
| 10/18/2019 | -9.22% | HC Wainwright & Co. | → 13 美元 | 启动覆盖范围开启 | → 购买 |
| 2019 年 11 月 7 日 | — | 坎托·菲茨杰拉德 | 升级 | 中性 → 超重 | |
| 11/06/2018 | 74.58% | 加拿大皇家银行资本 | 26 美元 → 25 美元 | 维护 | 跑赢大盘 |
What is the target price for Dynavax Technologies (DVAX)?
Dynavax Technologies (DVAX) 的目标价格是多少？
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by JMP Securities on November 3, 2023. The analyst firm set a price target for $27.00 expecting DVAX to rise to within 12 months (a possible 88.55% upside). 9 analyst firms have reported ratings in the last year.
JMP Securities于2023年11月3日公布了戴纳瓦克斯科技（纳斯达克股票代码：DVAX）的最新目标股价。该分析公司将目标股价定为27.00美元，预计DVAX将在12个月内升至12个月内（可能上涨88.55％）。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Dynavax Technologies (DVAX)?
Dynavax Technologies (DVAX) 的最新分析师评级是多少？
The latest analyst rating for Dynavax Technologies (NASDAQ: DVAX) was provided by JMP Securities, and Dynavax Technologies maintained their market outperform rating.
Dynavax Technologies（纳斯达克股票代码：DVAX）的最新分析师评级由JMP Securities提供，Dynavax Technologies维持其跑赢大盘的评级。
When is the next analyst rating going to be posted or updated for Dynavax Technologies (DVAX)?
Dynavax Technologies（DVAX）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Dynavax Technologies的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Dynavax Technologies的最新评级是在2023年11月3日发布的，因此您应该预计下一个评级将在2024年11月3日左右公布。
Is the Analyst Rating Dynavax Technologies (DVAX) correct?
分析师对Dynavax Technologies (DVAX) 的评级正确吗？
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a maintained with a price target of $25.00 to $27.00. The current price Dynavax Technologies (DVAX) is trading at is $14.32, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的戴纳瓦克斯科技（DVAX）评级维持不变，目标股价为25美元至27.00美元。Dynavax Technologies（DVAX）目前的交易价格为14.32美元，超出了分析师的预期区间。
